The research was spearheaded by Dr. Tobi Hamza, a resident emergency medicine physician at Mohammed V Military Teaching Hospital in Rabat, Morocco. Confronted with recurrent challenges in NIV tolerance linked to anxiety and discomfort during acute respiratory distress, Dr. Hamza and his colleagues hypothesized that hypnosis—a non-pharmacological technique—could mitigate such barriers and improve both tolerance and clinical outcomes. Over a six-month recruitment period, twenty patients presenting with acute respiratory failure at the hospital’s emergency department were enrolled in a rigorous prospective pilot trial. They were randomized into two equal groups: one receiving conventional NIV coupled with sedation and anti-anxiety medication as required, and the other receiving hypnosis sessions synchronized with NIV, without routine sedative drugs.

The hypnosis intervention was methodical and tailored. It began with a calming induction phase employing voice-guided relaxation, synchronized breathing, and vivid visual imagery to anchor patients’ focus and alleviate anxiety. Subsequently, a deepening phase aimed to facilitate dissociation from physical distress, aiming to diminish the psychological discomfort associated with mask-wearing. The final therapeutic suggestion phase was crafted to instill a profound sense of safety, trust in the treatment, and active cooperation with NIV. Crucially, all hypnosis sessions were conducted by an emergency physician trained extensively in medical hypnosis, enhancing fidelity and patient engagement.

Tolerance to NIV was quantified using a comprehensive comfort score ranging from zero to ten, supplemented by objective measurements of arterial blood gases including oxygen, carbon dioxide, and pH levels at one and four-hour intervals. Additionally, sedation and anti-anxiety medication requirements, levels of agitation, respiratory distress scores, and any need to abort NIV were carefully documented. The results were striking: the hypnosis cohort demonstrated significantly enhanced tolerance, with 80% completing their NIV treatment successfully without sedation or transitioning to invasive ventilation, in contrast to only 50% in the control group.

Beyond improved compliance, hypnosis yielded tangible clinical benefits. Notably, patients receiving hypnosis exhibited faster normalization of acid-base balance—demonstrated by improved pH—and more effective reduction of carbon dioxide retention after four hours. A reduction in agitation and respiratory distress scores, a decrease in emergency room length of stay, and a diminished reliance on anti-anxiety medications collectively underscored the therapeutic promise of hypnosis. Furthermore, patients subjected to the hypnotic intervention consistently provided higher comfort ratings, averaging 7.5 versus 4.3 in the control group, highlighting the subjective efficacy of this approach.

This study represents one of the earliest prospective clinical evaluations of hypnosis as an adjunct during NIV in acute respiratory failure, an area historically unexplored within emergency medicine. While hypnosis has found applications in pain management, procedural anxiety, and chronic disease care, its deployment in acute respiratory emergencies stands as a novel frontier. The pilot nature and small sample size of this trial warrant cautious interpretation, but the magnitude of observed benefits has galvanized further research efforts. Dr. Hamza and his team have initiated a larger, multicenter trial designed to validate these findings and examine long-term endpoints including hospitalization duration, intubation rates, and mortality.

The study’s strengths include its prospective design within a real-world emergency department, where the hypnosis was administered by a trained emergency physician, reflecting clinical feasibility. Limitations include single-center enrollment, potential selection bias as extreme emergencies and patients unable to consent were excluded, and lack of blinding for clinicians and patients, which could introduce placebo effects or observer bias. The specialized skills required to perform medical hypnosis may restrict immediate scalability until more healthcare providers receive appropriate training.

Independent expert Dr. Felix Lorang, head of the emergency department at SRH Zentralklinikum Suhl in Germany, emphasized the importance of communication in NIV adherence. Expressing intrigue about the findings, he noted that hypnosis intensifies patient-clinician interaction beyond standard verbal reassurance and shows promise in improving both patient comfort and the physiological efficacy of ventilation. Dr. Lorang advocated for larger-scale studies to confirm these encouraging results.

The convergence of hypnotic technique with emergency respiratory care heralds an exciting paradigm shift toward integrative, patient-centric management of acute respiratory distress. By harnessing the mind-body connection, hypnosis offers a low-cost, non-invasive, and drug-free complement to existing NIV protocols. Such innovations carry potential not only to improve therapeutic adherence and clinical outcomes but to reduce pharmacologic side effects and healthcare resource utilization. As respiratory diseases like COPD and pneumonia remain leading causes of morbidity and mortality globally, augmenting emergency interventions with hypnosis could substantially impact patient care.

Looking ahead, broader adoption of hypnosis in emergency settings hinges on rigorous evidence from multicenter randomized trials, standardization of hypnotic protocols, and incorporation into medical training curricula. If substantiated, hypnosis could redefine supportive care for patients suffering from life-threatening respiratory compromise. This study thus opens a vital research avenue at the intersection of cognitive psychology and emergency medicine, inviting ongoing exploration of non-conventional techniques to optimize critical care delivery.

The pilot study’s findings are poised to resonate across both clinical and academic communities, sparking dialogue on novel, integrative approaches to managing acute respiratory failure. The intersection of neuroscience and respiratory therapy exemplifies the future of medicine where holistic patient care enhances physiological healing. As investigations continue, the medical community awaits validation of hypnosis as a transformative adjunct in life-saving respiratory treatments.

Subject of Research: People

Article Title: Hypnosis to improve tolerance and efficacy of non-invasive ventilation in acute respiratory failure: a prospective controlled study

News Publication Date: 29-Sep-2025

References:

1. Abstract no: OA019, “Hypnosis to improve tolerance and efficacy of non-invasive ventilation in acute respiratory failure: a prospective controlled study” by Tobi Hamza, Best Abstracts session, Monday 29 September, 14:45-16:15-hrs CEST, Schubert 4 room.
2. Medical insights on the impact of carbon dioxide on blood acidity.

Image Credits: Tobi Hamza

Keywords:
Emergency medicine, Hypnosis, Respiratory disorders, Asthma, Bronchitis, Chronic obstructive pulmonary disease, Emphysema, Respiratory failure, Emergency rooms, Hospitals, Medical facilities

When trauma occurs, the clock begins ticking for the affected individuals; every second can influence their chances of survival. Blood is a vital resource in this equation, frequently administered before patients even reach the hospital. Traditionally, health professionals have relied on whole blood or packed red cells as a primary intervention. However, the latest findings suggest that targeted use of blood subcomponents, such as separated plasma, may significantly enhance recovery outcomes, particularly in cases of TBI and shock.

In the study, the research team observed that patients receiving separated plasma experienced better outcomes and fewer complications when compared to those treated with whole blood. These participants demonstrated improved coagulation markers upon arrival at the hospital, as well as a decrease in the volume of post-admission transfusions required. This disparity prompted further investigation into the mechanism by which plasma exerts such beneficial effects and raised pivotal questions about the storage and composition differences between whole blood and plasma.

Plasma is the yellowish liquid component of blood that remains after red blood cells, white blood cells, and platelets have coagulated. It contains essential proteins vital for various bodily functions, including the formation of blood clots and the overall inflammatory response. When trauma occurs, the body’s response typically includes a rush of clotting factors, proteins, and enzymes to mitigate damage and promote healing. The study’s researchers embarked on a detailed analysis of these proteins, identifying over 7,500 in samples collected from both healthy donors and trauma patients. Interestingly, only 198 proteins emerged as highly relevant to the processes involved in inflammation and clotting following injury.

The researchers postulated that while whole blood holds the same volume of plasma as separated plasma products, there might be crucial differences arising during storage. Whole blood can be stored for up to 21 days, while separated plasma has a much shorter shelf life of approximately five days. This temporal aspect raises concerns regarding protein integrity, as prolonged storage in whole blood could alter the efficacy of plasma-derived components due to the degradation of certain proteins over time.

As the clinical implications of this research unfold, the logistical challenges associated with transporting separated plasma remain a formidable barrier. Many emergency services lack the capability to maintain the necessary storage conditions for plasma, leading to wastage and operational difficulties in most ambulance services. However, the researchers advocate that these challenges should be addressed head-on, emphasizing the life-saving potentials associated with administering the right blood products to the right patients in a timely manner.

The study encompassed a multicenter effort known as the Shock, Whole Blood, and Assessment of TBI (SWAT) study, which enrolled over 1,000 traumatized subjects with significant probabilities of requiring emergency surgery. A specific subgroup of patients who had sustained multiple injuries was further analyzed, relying on complex computational methods to filter out confounding factors like age and gender from their assessment. The results indicated a clear benefit from the administration of higher proportions of plasma among those suffering from severe shock and notable TBI markers.

Future investigations will be critical not only for confirming these findings but also for developing practical applications to improve patient care. The researchers express optimism toward creating protocols that can be adopted by transport teams, thereby integrating the advantages of separated plasma in treating trauma patients. As evidence continues to mount favoring precision transfusion, it becomes increasingly essential for the medical community to collaborate across specialties to establish cohesive approaches aimed at enhancing trauma outcomes.

Different research avenues are undoubtedly essential; exploring the variability of individual proteomic profiles in donor plasma can provide deeper insights into how this therapeutic strategy can evolve. As trauma medicine adopts more nuanced techniques, it leads the way toward a future where optimized transfusions are the standard rather than the exception.

Finally, while logistical issues regarding the availability of separated plasma can pose a challenge, the recognition of its potential advantages marks a significant step forward in trauma care. Engaging in these transformative practices can ensure that patients receive the most effective care tailored to their specific conditions, ultimately enhancing survival rates and recovery.

In conclusion, the shift from traditional blood transfusion practices toward a more precision-oriented approach symbolizes a broader transition to advanced, patient-centered medical treatments in emergency medicine. As the research community continues to unravel the complexities of transfusion science, the possibilities for improved patient outcomes seem more promising than ever.

Subject of Research: Precision Transfusion in Trauma Care
Article Title: High-dimensional Analysis of Injured Patients Reveals Distinct Circulating Proteomic Profiles in Plasma vs. Whole Blood Resuscitation
News Publication Date: 18-Mar-2025
Web References: https://www.medschool.pitt.edu/, https://www.upmc.com/, https://doi.org/10.1016/j.xcrm.2025.102022
References: –
Image Credits: Credit: UPMC
Keywords: Blood transfusion, Blood plasma, Protein markers, Brain injuries, Clinical research, Discovery research, Proteomics, Inflammation, Blood donation, Bleeding.